Skip to main content
Watch Insiders

Corporate insider profile

Gwenn Hansen Insider Trades

Latest reported as Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX).

Purchase filings
0
Reported companies
1
Net open-market value
-$533,655.56
Latest transaction
Oct 15, 2026

Affiliated corporations

Reported company relationships

NRIXLatest reported

Nurix Therapeutics, Inc.

Chief Scientific Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 15, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale1,452$25.00$36,300
Sep 1, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale1,452$25.47$36,982
Aug 5, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale4,356$25.00$108,900
Aug 4, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale4,111$24.36$100,141
Jul 30, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale3,847$23.38$89,954
Jun 25, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale5,394$20.00$107,880
Apr 30, 2026Nurix Therapeutics, Inc. (NRIX)Chief Scientific OfficerSale3,214$16.65$53,498